Certain phorbol esters, polar solvents and retinoids have been identified as in vitro and in vivo inducers of human myeloid leukemia cell differentiation. However, the mechanisms by which these diverse classes of agents induce differentiation remain unclear. Our previous studies focused on transcriptional activation of the c-jun and EGR-1 early response genes. The available evidence supports the involvement of these genes in induction of the differentiated myeloid phenotype. Moreover, identification of the cis-acting elements responsible for activation of c-jun and EGR-1 provided the basis for demonstrating involvement of a Raf-1/MAP kinase/pp90rsk signaling cascade. Other studies supported by this grant have provided evidence that differentiation of myeloid leukemia cells is associated with induction of apoptosis. The proposed work will extend the recent finding that differentiation of myeloid leukemia cells includes induction of the stress activated protein (SAP, JNK) kinase. Our hypothesis is that activation of the SAP kinase pathway may contribute to the """"""""switch"""""""" that directs a cell to differentiate rather than proliferate. The finding that the nuclear c-Abl protein tyrosine kinase, which acts upstream to SAP kinase, is activated by differentiating agents has provided the basis for studying involvement of a c-Abl- greater SAP kinase cascade. The formation of a nuclear complex involving c-Abl, a Src-like kinase and a protein tyrosine phosphatase will be studied as a mechanism for regulating the differentiation program. The recent findings that SAP kinase contributes to induction of apoptosis provides further support for the involvement of this pathway in a process of terminal differentiation. These issues will be addressed in the proposed work.
The Specific Aims are: 1) To define the signaling mechanisms responsible for induction of SAP kinase activity in myeloid leukemia cell differentiation; 2) To study the functional significance of a novel nuclear signaling cascade in differentiation of myeloid leukemia cells; 3) To study the functional involvement of Src-like protein tyrosine kinases in induction of leukemic cell differentiation; 4) To define the signaling events responsible for apoptosis associated with terminal differentiation of myeloid leukemia cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA042802-11
Application #
2007582
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1986-08-01
Project End
2002-01-31
Budget Start
1997-02-06
Budget End
1998-01-31
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Jain, Salvia; Stroopinsky, Dina; Yin, Li et al. (2015) Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Blood 126:354-62
Raina, Deepak; Agarwal, Praveen; Lee, James et al. (2015) Characterization of the MUC1-C Cytoplasmic Domain as a Cancer Target. PLoS One 10:e0135156
Yin, Li; Kufe, Turner; Avigan, David et al. (2014) Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death. Blood 123:2997-3006
Liu, Suiyang; Yin, Li; Stroopinsky, Dina et al. (2014) MUC1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cells. Blood 123:734-42
Liu, Yan; Marks, Kevin; Cowley, Glenn S et al. (2013) Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer. Cancer Discov 3:870-9
Stroopinsky, Dina; Rosenblatt, Jacalyn; Ito, Keisuke et al. (2013) MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells. Cancer Res 73:5569-79
Jin, C; Rajabi, H; Rodrigo, C M et al. (2013) Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein. Oncogene 32:2179-88
Jin, Caining; Rajabi, Hasan; Pitroda, Sean et al. (2012) Cooperative interaction between the MUC1-C oncoprotein and the Rab31 GTPase in estrogen receptor-positive breast cancer cells. PLoS One 7:e39432
Ahmad, Rehan; Alam, Maroof; Rajabi, Hasan et al. (2012) The MUC1-C oncoprotein binds to the BH3 domain of the pro-apoptotic BAX protein and blocks BAX function. J Biol Chem 287:20866-75
Raina, Deepak; Ahmad, Rehan; Rajabi, Hasan et al. (2012) Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells. Int J Oncol 40:1643-9

Showing the most recent 10 out of 130 publications